Life Scientist > Health & Medical

Prima in high-level licensing talks

18 February, 2002 by Tanya Hollis

Prima BioMed has commenced preliminary talks with several major drug companies over potential licensing options for its new anti-inflammatory compound,VIB 153.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd